earnings
confidence high
sentiment positive
materiality 0.75
Charles River Q3 results beat; narrows and raises non-GAAP EPS guidance for 2023
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
2023-Q3 EPS reported
$5.58
revenue$3,115,933,000
- Q3 revenue $1.03B (+3.8% YoY); GAAP EPS $1.69 (-10.1%), non-GAAP EPS $2.72 (+3.4%).
- Organic revenue growth 4.1%, driven by DSA (+5.3% organic) and RMS (+3.2% organic).
- DSA segment GAAP operating margin down to 22.1% from 22.9%; non-GAAP up to 27.2% from 26.2%.
- RMS GAAP op margin 15.2% vs 19.9% prior; Manufacturing op margin down on GAAP and non-GAAP basis.
- FY2023 guidance: organic rev growth 5.5%-6.5% (narrowed from 5.5%-7.5%); non-GAAP EPS $10.50-$10.70 (prior $10.30-$10.90).